Home / Blood Tests / Stockholm3

Stockholm3

Stockholm3 has been developed by researchers at Karolinska Institutet. Studies have shown that compared with the current standard PSA test (prostate-specific antigen), Stockholm3 yields more accurate and clearer test results for early detection of prostate cancer. Stockholm3 finds 100 percent more aggressive prostate cancers and reduce unnecessary biopsies by 50 percent compared to current practice. Stockholm3 has been tested on more than 75,000 men and provides a clear result and clear recommendations. Healthcare providers in Sweden and Norway, who have replaced PSA with Stockholm3, show that direct care costs are reduced by 17 to 28 percent.

There is an additional £20 phlebotomy fee for every donation.